http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2102985-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba9fccfd6f1883c207af22d35b231c91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 1995-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16a0da30d9f54ef86fa496ee6a77ecb7
publicationDate 1998-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2102985-C1
titleOfInvention Method of hyperactive cell suppression
abstract FIELD: medicine, oncology. SUBSTANCE: method involves effect of DNA acid hydrolyzate containing pyrimidine nucleotides from wheat embryos on tumor cells under conditions in vitro. EFFECT: broadened range of biomaterials showing antitumor effect. 3 cl
priorityDate 1995-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410062813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547251

Total number of triples: 22.